Market Cap

Illumina, Inc. Market Capitalization:

$20.87 Billion

USD as of Jan. 1, 2024

business Illumina, Inc. Company Profile

Illumina, Inc. Main Stock Listing

NASDAQ: ILMN

Market Capitalization History of Illumina, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $207.62 B
Danaher $171.89 B
Siemens Healthineers AG $66.05 B
DexCom, Inc. $46.50 B
IDEXX Laboratories, Inc. $44.72 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Illumina, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $20.87 B -33.95%
Jan. 1, 2023 $31.60 B -40.80%
Jan. 1, 2022 $53.37 B -18.20%
Jan. 1, 2021 $65.25 B 47.01%
Jan. 1, 2020 $44.38 B 3.67%
Jan. 1, 2019 $42.81 B 20.27%
Jan. 1, 2018 $35.59 B 45.31%
Jan. 1, 2017 $24.50 B 1.36%
Jan. 1, 2016 $24.17 B -19.08%
Jan. 1, 2015 $29.86 B 28.41%
Jan. 1, 2014 $23.26 B 200.22%
Jan. 1, 2013 $7.75 B -2.37%
Jan. 1, 2012 $7.93 B -25.21%
Jan. 1, 2011 $10.61 B 88.99%
Jan. 1, 2010 $5.61 B 34.10%
Jan. 1, 2009 $4.19 B -14.10%
Jan. 1, 2008 $4.87 B 55.94%
Jan. 1, 2007 $3.13 B 90.53%
Jan. 1, 2006 $1.64 B 121.26%
Jan. 1, 2005 $741.3 M 10.74%
Jan. 1, 2004 $669.4 M 191.67%
Jan. 1, 2003 $229.5 M -64.50%
Jan. 1, 2002 $646.4 M -59.76%
Jan. 1, 2001 $1.61 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Company Description

Illumina, Inc. is a biotechnology company specialized in DNA sequencing. It develops, manufactures, and markets genetic and biological analysis systems dedicated to the markets of gene sequencing, genotyping and gene expression, and proteomics. Thanks to its products, Illumina has been able to dramatically reduce the cost of human genome sequencing.

business Illumina, Inc. Company Profile

Illumina, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Illumina, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ILMN

Stock: BMV: ILMN

Stock: Bovespa: I1LM34

Stock: FSX: ILU

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.